Article Details

J&J-Linked Rapport Therapeutics Files For IPO - Morningstar

Retrieved on: 2024-05-17 20:46:53

Tags for this article:

Click the tags to see associated articles and topics

J&J-Linked Rapport Therapeutics Files For IPO - Morningstar. View article details on hiswai:

Excerpt

The company was founded in 2022 with the support of Johnson & Johnson Innovation and Third Rock Ventures. Chief Scientific Officer David Bredt ...

Article found on: www.morningstar.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo